Submitted by admin on Fri, 2025-04-25 13:25

Vyepti

  • Brand name/Generic name: Vyepti/eptinezumab-jjmr
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: thirty minutes
  • Frequency of Treatment: every twelve weeks
  • Conditions this Medication Treats: migraine prevention
  • Link for more Information: https://www.vyepti.com/
Submitted by admin on Fri, 2025-04-25 13:25

Ultomiris

  • Brand name/Generic name: Ultomiris/ravulizumab-cwvz
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: approximately 30 to 90 minutes depending on dose
  • Frequency of Treatment: varies based on dose
  • Conditions this Medication Treats:
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • atypical hemolytic uremic syndrome (aHUS)
    • generalized myasthenia gravis (gMG)
    • neuromyelitis optica spectrum disorder (NMOSD)
Submitted by admin on Fri, 2025-04-25 13:25

Tysabri

  • Brand name/Generic name: Tysabri/natalizumab
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: approximately one hour followed by an hour of observation
  • Frequency of Treatment: every four weeks
  • Conditions this Medication Treats: relapsing multiple sclerosis, Crohn disease
  • Link for more Information: https://www.tysabri.com/
Submitted by admin on Fri, 2025-04-25 13:24

Tremfya

  • Brand name/Generic name: Tremfya/guselkumab
  • How Administered at HOA: intravenous infusion/subcutaneous injection
  • Duration of Treatment: 60 minutes infusion/fast subcutaneous injection
  • Frequency of Treatment: every four weeks for the first two doses and every eight weeks thereafter
  • Conditions this Medication Treats:
    • Crohn disease
    • ulcerative colitis
    • plaque psoriasis
    • psoriatic arthritis
Submitted by admin on Fri, 2025-04-25 13:24

Tezspire

  • Brand name/Generic name: Tezspire/tezepelumab-ekko
  • How Administered at HOA: subcutaneous injection
  • Duration of Treatment: fast subcutaneous injection
  • Frequency of Treatment: every four weeks
  • Conditions this Medication Treats: severe asthma
  • Link for more Information: https://www.tezspire.com/
Submitted by admin on Fri, 2025-04-25 13:24

Tepezza

  • Brand name/Generic name: Tepezza/teprotumamab-trbw
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: 90 minutes for the first two infusions and 60 minutes thereafter
  • Frequency of Treatment: every three weeks for eight infusions
  • Conditions this Medication Treats: Thyroid eye disease (TED)
  • Link for more Information: https://www.tepezza.com/
Submitted by admin on Fri, 2025-04-25 13:24

Stelara

  • Brand name/Generic name: Stelara/ustekinumab
  • How Administered at HOA: intravenous induction followed by subcutaneous injection maintenance
  • Duration of Treatment: 60 minutes (intravenous)/fast subcutaneous injection
  • Frequency of Treatment: varies depending on indication
  • Conditions this Medication Treats:
    • Crohn disease
    • ulcerative colitis
    • plaque psoriasis
    • psoriatic arthritis
Submitted by admin on Fri, 2025-04-25 13:24

Soliris

  • Brand name/Generic name: Soliris/eculizumab
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: thirty five minutes
  • Frequency of Treatment: once per week for the first 5 weeks and once every 2 weeks thereafter
  • Conditions this Medication Treats: anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD), paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome, myasthenia gravis
Submitted by admin on Fri, 2025-04-25 13:23

Skyrizi

  • Brand name/Generic name: Skyrizi/risankizumab-rzaa
  • How Administered at HOA:
    • subcutaneous injection for psoriasis and ulcerative colitis
    • intravenous infusion for Crohn’s disease
  • Duration of Treatment:
    • one hour for Crohn’s disease
    • two hours for ulcerative colitis
  • Frequency of Treatment: every four weeks
  • Conditions this Medication Treats:
    • Plaque psoriasis
    • Psoriatic arthritis
Submitted by admin on Fri, 2025-04-25 13:23

Rituxan

  • Brand name/Generic name: Rituxan/rituximab
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: after first dose between three to four hours
  • Frequency of Treatment: varies based on indication
  • Conditions this Medication Treats:
    • rheumatoid arthritis
    • Granulomatosis with Polyangiitis (GPA)
    • Pemphigus Vulgaris (PV)

Pages